Correlation Between ATT and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATT and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and Mydecine Innovations Group, you can compare the effects of market volatilities on ATT and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and Mydecine Innovations.

Diversification Opportunities for ATT and Mydecine Innovations

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between ATT and Mydecine is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of ATT i.e., ATT and Mydecine Innovations go up and down completely randomly.

Pair Corralation between ATT and Mydecine Innovations

Taking into account the 90-day investment horizon ATT is expected to generate 63.94 times less return on investment than Mydecine Innovations. But when comparing it to its historical volatility, ATT Inc is 36.74 times less risky than Mydecine Innovations. It trades about 0.05 of its potential returns per unit of risk. Mydecine Innovations Group is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  48.00  in Mydecine Innovations Group on August 26, 2024 and sell it today you would lose (47.50) from holding Mydecine Innovations Group or give up 98.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ATT Inc  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
ATT Inc 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in ATT Inc are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, ATT unveiled solid returns over the last few months and may actually be approaching a breakup point.
Mydecine Innovations 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

ATT and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATT and Mydecine Innovations

The main advantage of trading using opposite ATT and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind ATT Inc and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
CEOs Directory
Screen CEOs from public companies around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings